A low level of LBCS therefore contributes to the upregulation of SOX2, a previously confirmed marker for stem-like tumor cells in BC [137] and thus to chemoresistance of BCSC (Figure 2). The gene discussed is LNC-LBCS; the disease is neoplasm.